Literature DB >> 8423072

Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis.

S Carlucci1, A Beschin, L Tuosto, F Ameglio, G M Gandolfo, C Cocito, F Fiorucci, C Saltini, E Piccolella.   

Abstract

The Mycobacterium bovis antigen complex A60 is known to be immunodominant in tuberculosis and to have a protective effect against experimental infection in vitro and in vivo. To identify immunodominant and possibly protective antigens in pulmonary tuberculosis, the T-cell repertoire directed to nitrocellulose-bound fractions of A60 antigen was analyzed in active tuberculosis patients during the course of the infection and after recovery. The results show that patients infected with Mycobacterium tuberculosis acquired complete A60-T-cell reactivity only in the late phases of infection. At disease onset, patients with active tuberculosis were characterized by (i) T-cell unresponsiveness to most A60 fractions, (ii) high tumor necrosis factor alpha production, and (iii) low gamma interferon (IFN-gamma) release. Several weeks after chemotherapy, the unresponsive state disappeared and the following reverse situation was observed: (i) high blastogenic response to almost all A60 fractions, (ii) low tumor necrosis factor alpha release, and (iii) high IFN-gamma production. In addition, 60% of these patients significantly responded against seven A60 fractions (61 to 58, 56 to 53, 49 to 46, 46 to 44, 35 to 33, 33 to 30, and 30 to 28 kDa), indicating that they included immunodominant antigens. Furthermore, only the fractions within the molecular mass ranges of 56 to 44 and 35 to 28 kDa induced IFN-gamma synthesis. One year after complete recovery from infection, more than 60% of past-active tuberculosis subjects had memory T cells specific for the immunodominant fractions of 61 to 58, 56 to 53, 49 to 46, and 33 to 30 kDa. Since the same fractions induced the strongest IFN-gamma production, known to exhibit antimycobacterial effects, it is suggested that these may represent the inducers of a protective immune response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423072      PMCID: PMC302748          DOI: 10.1128/iai.61.2.439-447.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Suppressor adherent cells in human tuberculosis.

Authors:  J J Ellner
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Mechanism of action of an antigen nonspecific inhibitory factor produced by human T cells stimulated by MPPS and PPD.

Authors:  G Lombardi; A M Di Massimo; F Del Gallo; D Vismara; E Piccolella; O Pugliese; V Colizzi
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness.

Authors:  J M Grange
Journal:  Adv Tuberc Res       Date:  1984

5.  The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system.

Authors:  O Closs; M Harboe; N H Axelsen; K Bunch-Christensen; M Magnusson
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

6.  Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.

Authors:  M E Kleinhenz; J J Ellner; P J Spagnuolo; T M Daniel
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

7.  Quantification of antigen-reactive cells among human T lymphocytes.

Authors:  M H van Oers; J Pinkster; W P Zeijlemaker
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

8.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Production of a suppressor factor by human adherent cells treated with mycobacteria.

Authors:  A A Wadee; R Sher; A R Rabson
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  8 in total

1.  Serological comparison of purified antigens 60 and 85A (P32) of Mycobacterium bovis BCG, and purified protein derivative, in active pulmonary tuberculosis.

Authors:  M Turneer; E Van Nerom
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

Review 2.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

3.  Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins.

Authors:  D M Russo; N Kozlova; D L Lakey; D Kernodle
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis.

Authors:  M Torres; T Herrera; H Villareal; E A Rich; E Sada
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  Antigen provoking gamma interferon production in response to Mycobacterium bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice.

Authors:  I Kawamura; J Yang; Y Takaesu; M Fujita; K Nomoto; M Mitsuyama
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Immunological analysis of the components of the antigen complex A60 of Mycobacterium bovis BCG.

Authors:  C Coetsier; M C Baelden; M Coene; C Cocito
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

7.  Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.

Authors:  Han-Gyu Choi; Seunga Choi; Yong Woo Back; Seungwha Paik; Hye-Soo Park; Woo Sik Kim; Hongmin Kim; Seung Bin Cha; Chul Hee Choi; Sung Jae Shin; Hwa-Jung Kim
Journal:  Oncotarget       Date:  2017-03-21

8.  Evaluation of anti-A60 antigen IgG enzyme-linked immunosorbent assay for serodiagnosis of pulmonary tuberculosis.

Authors:  Zakeya Abdulbaqi Bukhary
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.